Study of Shared Decision Making Tools for Patients with Renal Cell Carcinoma to Improve Treatment Choices

What this Trial Is About

Researchers are evaluating the impact of two decision aids designed for patients with renal cell carcinoma RCC on how decisions about treatment are made and the quality of those decisions. This study focuses on both local non-metastatic and metastatic RCC, where treatment options vary widely depending on disease stage, tumor type, and patient preferences. The goal is to see how these decision aids affect shared decision-making between patients and healthcare professionals. The study compares usual care, where patients receive standard information, to care involving the use of two online interactive decision aidsone for local RCC and one for metastatic RCC. These aids explain treatment choices, outcomes, possible side effects, and benefits to help patients make informed decisions together with their doctors. The study is prospective and multicenter, involving groups before and after implementing the decision aids. Participants will be patients diagnosed with RCC who face treatment decisions covered by the aids. Assessments include observing shared decision-making during consultations and measuring decision quality, patient knowledge, and feelings about the decision process through questionnaires at intervals up to nine weeks after consultation. The study aims to evaluate changes in decision-making quality and how well the aids are implemented, with all data collected during and after consultations.

A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)